Health facilities in Mbarara City are struggling to keep up with surging demand for Lenacapavir, the revolutionary HIV prevention injection that only needs to be taken tw...
Medics in the Masaka sub-region have rolled out the use of injectable Lenacapavir amid calls for behavior change as a preventive measure in the fight against HIV.Addressi...
Uganda is preparing for a major shift in HIV treatment as researchers and health officials work towards introducing long-acting injectable antiretroviral therapy (ART) th...
The Uganda Peoples’ Defence Forces (UPDF), through its Health Services, has rolled out lenacapavir, a long-acting injectable Pre-Exposure Prophylaxis (PrEP) drug for HI...
David Ssenfuka (L) and President MuseveniPresident Yoweri Kaguta Museveni has appealed to Members of Parliament to prioritise funding of critical areas in this year’s b...
Global health is evolving rapidly, with breakthroughs turning into medicine.The latest advancement in viral research is Lenacapavir, an FDA-approved HIV injectable drug m...
Uganda has received its first 19,200 doses of Lenacapavir, a twice-yearly injectable HIV prevention drug supported by the Global Fund and PEPFAR, targeting high-burden di...
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could accelera...
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technolo...
According to the American Society of Plastic Surgeons, the Brazilian B*tt Lift, better known as a BBL, has become one of the defining cosmetic procedures of the last dec...
